97 related articles for article (PubMed ID: 20010244)
1. Retinal oxidative stress induced by intraocular hypertension in rats may be ameliorated by brimonidine treatment and N-acetyl cysteine supplementation.
Ozdemir G; Tolun FI; Gul M; Imrek S
J Glaucoma; 2009 Dec; 18(9):662-5. PubMed ID: 20010244
[TBL] [Abstract][Full Text] [Related]
2. Effect of hyaluronic acid on intraocular pressure in rats.
Benozzi J; Nahum LP; Campanelli JL; Rosenstein RE
Invest Ophthalmol Vis Sci; 2002 Jul; 43(7):2196-200. PubMed ID: 12091416
[TBL] [Abstract][Full Text] [Related]
3. Neuroprotection of retinal ganglion cells by brimonidine in rats with laser-induced chronic ocular hypertension.
WoldeMussie E; Ruiz G; Wijono M; Wheeler LA
Invest Ophthalmol Vis Sci; 2001 Nov; 42(12):2849-55. PubMed ID: 11687528
[TBL] [Abstract][Full Text] [Related]
4. Effect of ocular hypertension on retinal nitridergic pathway activity.
Belforte N; Moreno MC; Cymeryng C; Bordone M; Keller Sarmiento MI; Rosenstein RE
Invest Ophthalmol Vis Sci; 2007 May; 48(5):2127-33. PubMed ID: 17460271
[TBL] [Abstract][Full Text] [Related]
5. Curcumin protects rats against acetaminophen-induced hepatorenal damages and shows synergistic activity with N-acetyl cysteine.
Kheradpezhouh E; Panjehshahin MR; Miri R; Javidnia K; Noorafshan A; Monabati A; Dehpour AR
Eur J Pharmacol; 2010 Feb; 628(1-3):274-81. PubMed ID: 19919835
[TBL] [Abstract][Full Text] [Related]
6. Salutary effects of N-acetylcysteine on apoptotic damage in a rat model of testicular torsion.
Payabvash S; Salmasi AH; Kiumehr S; Tavangar SM; Nourbakhsh B; Faghihi SH; Dehpour AR
Urol Int; 2007; 79(3):248-54. PubMed ID: 17940358
[TBL] [Abstract][Full Text] [Related]
7. Alteration of retinal intrinsic survival signal and effect of alpha2-adrenergic receptor agonist in the retina of the chronic ocular hypertension rat.
Kim HS; Chang YI; Kim JH; Park CK
Vis Neurosci; 2007; 24(2):127-39. PubMed ID: 17640403
[TBL] [Abstract][Full Text] [Related]
8. A randomized, investigator-masked, 4-week study comparing timolol maleate 0.5%, brinzolamide 1%, and brimonidine tartrate 0.2% as adjunctive therapies to travoprost 0.004% in adults with primary open-angle glaucoma or ocular hypertension.
Reis R; Queiroz CF; Santos LC; Avila MP; Magacho L
Clin Ther; 2006 Apr; 28(4):552-9. PubMed ID: 16750466
[TBL] [Abstract][Full Text] [Related]
9. Beneficial effects of N-acetylcysteine on sodium taurocholate-induced pancreatitis in rats.
Yagci G; Gul H; Simsek A; Buyukdogan V; Onguru O; Zeybek N; Aydin A; Balkan M; Yildiz O; Sen D
J Gastroenterol; 2004; 39(3):268-76. PubMed ID: 15065005
[TBL] [Abstract][Full Text] [Related]
10. Effect of N-acetylcysteine on carboplatin-induced ototoxicity and nitric oxide levels in a rat model.
Okur E; Kilinc M; Yildirim I; Kilic MA; Tolun FI
Laryngoscope; 2007 Dec; 117(12):2183-6. PubMed ID: 17909450
[TBL] [Abstract][Full Text] [Related]
11. Role of oxidative stress in pathophysiology of peripheral neuropathy and modulation by N-acetyl-L-cysteine in rats.
Naik AK; Tandan SK; Dudhgaonkar SP; Jadhav SH; Kataria M; Prakash VR; Kumar D
Eur J Pain; 2006 Oct; 10(7):573-9. PubMed ID: 16214382
[TBL] [Abstract][Full Text] [Related]
12. Brimonidine tartrate 0.15%, dorzolamide hydrochloride 2%, and brinzolamide 1% compared as adjunctive therapy to prostaglandin analogs.
Bournias TE; Lai J
Ophthalmology; 2009 Sep; 116(9):1719-24. PubMed ID: 19592108
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the effects of dorzolamide-timolol fixed combination and brimonidine on intraocular pressure after phacoemulsification surgery.
Ozkurt Y; Oral Y; Karacan O; Comez A; Dogan OK
Eye Contact Lens; 2008 Jan; 34(1):21-3. PubMed ID: 18180678
[TBL] [Abstract][Full Text] [Related]
14. Effect of topical brinzolamide 1% and brimonidine 0.2% on intraocular pressure after phacoemulsification.
Cetinkaya A; Akman A; Akova YA
J Cataract Refract Surg; 2004 Aug; 30(8):1736-41. PubMed ID: 15313300
[TBL] [Abstract][Full Text] [Related]
15. Anterior and posterior segment changes in rat eyes with chronic steroid administration and their responsiveness to antiglaucoma drugs.
Razali N; Agarwal R; Agarwal P; Kapitonova MY; Kannan Kutty M; Smirnov A; Salmah Bakar N; Ismail NM
Eur J Pharmacol; 2015 Feb; 749():73-80. PubMed ID: 25481859
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of brimonidine and dorzolamide for intraocular pressure lowering in glaucoma and ocular hypertension.
Katz LJ; Simmons ST; Craven ER
Curr Med Res Opin; 2007 Dec; 23(12):2971-83. PubMed ID: 17949534
[TBL] [Abstract][Full Text] [Related]
17. Role of ellagic acid against cisplatin-induced nephrotoxicity and oxidative stress in rats.
Ateşşahín A; Ceríbaşi AO; Yuce A; Bulmus O; Cikim G
Basic Clin Pharmacol Toxicol; 2007 Feb; 100(2):121-6. PubMed ID: 17244261
[TBL] [Abstract][Full Text] [Related]
18. Retinal ganglion cell neuroprotection in a rat model of glaucoma following brimonidine, latanoprost or combined treatments.
Hernández M; Urcola JH; Vecino E
Exp Eye Res; 2008 May; 86(5):798-806. PubMed ID: 18394603
[TBL] [Abstract][Full Text] [Related]
19. [Protective effect of N-acetylcysteine on acute lung injury caused by exposure to rocket liquid propellant].
Liu S; Yu SY
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2004 Oct; 16(10):611-4. PubMed ID: 15461841
[TBL] [Abstract][Full Text] [Related]
20. Apraclonidine 0.5% versus brimonidine 0.2% for the control of intraocular pressure elevation following anterior segment laser procedures.
Chevrier RL; Assalian A; Duperré J; Lesk MR
Ophthalmic Surg Lasers; 1999 Mar; 30(3):199-204. PubMed ID: 10100253
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
